Loading
·
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.